Scientists around the world are looking for a Covid-19 vaccine, as the number of infections reached 24 million worldwide on Thursday and up to 822,000 more people have died as a result of the virus.
Click here to complete the Covid-19
The United States has the number of instances in the global (5. 9 million), followed by Brazil (3. 72 million) and India (3. 31 million).
Here’s a look at the Covid-19 vaccines being tested:
Oxford ChAdOx1 nCoV-19 Vaccine
The vaccine is being developed through the University of Oxford according to the pharmaceutical company AstraZeneca. The phase II clinical trial of the vaccine, manufactured through the Serum Institute of India (SII) in India City, started at a medical school and hospital in Pune This vaccine is expected to be available until December 2020 and the estimated value of the vaccine will be $4 (Rs 295).
Moderna Vaccine
The mNR-1273 vaccine from us pharmaceutical company Moderna is in the third phase of its trial. The duration of the pattern for this trial is another 30,000 people and is expected to be completed until the end of September. vaccine until the end of this year. Its value ranges from Rs1,800 to Rs23. 00.
Look too. Covid Vaccine: India and Russia in talks after Putin-prepared drug
Sinopharm vaccine in China
Chinese company Sinopharm has announced that it will launch a Covid-19 vaccine until the end of 2020. The third test of this prospective vaccine is underway in the United Arab Emirates. Two doses of this vaccine would charge Rs 10,700.
CanSino Biologics Inc. Ad5-nCoV Vaccine
According to another Chinese company, CanSino Biologics Inc, its Covid-19 Ad5-nCoV vaccine has patent rights. This vaccine evolved into an agreement with the Beijing Institute of Biotechnology. The vaccine is also expected to be introduced until the end of this year. There have been no revelations about the value of the vaccine.
Russian Sputnik V
Russia claimed to have introduced the world’s first Covid-19 vaccine, Sputnik V, on 11 August. Russian President Vladimir Putin said the vaccine was and showed “stable immunity” opposed to coronavirus. However, the vaccine did not go through the third level of The Runway, which will involve no fewer than 40,000 volunteers. According to the Moscow-based Gamaleya Institute, the vaccine will be available until the end of September, but the value of the vaccine has not yet been announced.
“item. title”